-
1
-
-
0028204189
-
Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor
-
Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994;13:1176-88.
-
(1994)
EMBO J
, vol.13
, pp. 1176-1188
-
-
Bergers, G.1
Reikerstorfer, A.2
Braselmann, S.3
Graninger, P.4
Busslinger, M.5
-
2
-
-
0037432179
-
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
-
Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003;107:721-6.
-
(2003)
Circulation
, vol.107
, pp. 721-726
-
-
Weinberg, E.O.1
Shimpo, M.2
Hurwitz, S.3
Tominaga, S.4
Rouleau, J.L.5
Lee, R.T.6
-
3
-
-
2442621252
-
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
-
Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004;109:2186-90.
-
(2004)
Circulation
, vol.109
, pp. 2186-2190
-
-
Shimpo, M.1
Morrow, D.A.2
Weinberg, E.O.3
Sabatine, M.S.4
Murphy, S.A.5
Antman, E.M.6
-
4
-
-
57449089014
-
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load
-
Bartunek J, Delrue L, Van Durme F, Muller O, Casselman F, De Wiest B et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 2008;52:2166-74.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 2166-2174
-
-
Bartunek, J.1
Delrue, L.2
Van Durme, F.3
Muller, O.4
Casselman, F.5
De Wiest, B.6
-
5
-
-
79959709354
-
The IL-33/ST2 pathway - a new therapeutic target in cardiovascular disease
-
Miller AM, Liew FY. The IL-33/ST2 pathway - a new therapeutic target in cardiovascular disease. Pharmacol Ther 2011;131:179-86.
-
(2011)
Pharmacol Ther
, vol.131
, pp. 179-186
-
-
Miller, A.M.1
Liew, F.Y.2
-
6
-
-
27744446058
-
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
-
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
-
(2005)
Immunity
, vol.23
, pp. 479-490
-
-
Schmitz, J.1
Owyang, A.2
Oldham, E.3
Song, Y.4
Murphy, E.5
McClanahan, T.K.6
-
7
-
-
77949264462
-
Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling
-
Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail 2009;2:684-91.
-
(2009)
Circ Heart Fail
, vol.2
, pp. 684-691
-
-
Seki, K.1
Sanada, S.2
Kudinova, A.Y.3
Steinhauser, M.L.4
Handa, V.5
Gannon, J.6
-
8
-
-
80555126115
-
IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3 + cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival
-
Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K et al. IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3 + cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol 2011;187:4598-610.
-
(2011)
J Immunol
, vol.187
, pp. 4598-4610
-
-
Turnquist, H.R.1
Zhao, Z.2
Rosborough, B.R.3
Liu, Q.4
Castellaneta, A.5
Isse, K.6
-
9
-
-
34249882513
-
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
-
Sanada S, Hakuno D, Higgins L, Schreiter E, McKenzie AN, Lee R. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-49.
-
(2007)
J Clin Invest
, vol.117
, pp. 1538-1549
-
-
Sanada, S.1
Hakuno, D.2
Higgins, L.3
Schreiter, E.4
McKenzie, A.N.5
Lee, R.6
-
10
-
-
39549100797
-
IL-33 reduces the development of atherosclerosis
-
Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008;205:339-46.
-
(2008)
J Exp Med
, vol.205
, pp. 339-346
-
-
Miller, A.M.1
Xu, D.2
Asquith, D.L.3
Denby, L.4
Li, Y.5
Sattar, N.6
-
11
-
-
34548825396
-
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
-
Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282:26369-80.
-
(2007)
J Biol Chem
, vol.282
, pp. 26369-26380
-
-
Hayakawa, H.1
Hayakawa, M.2
Kume, A.3
Tominaga, S.4
-
12
-
-
77954842051
-
Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting
-
Flier S, Post J, Concepcion AN, Kappen TH, Kalkman CJ, Buhre WF. Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 2010;105:122-30.
-
(2010)
Br J Anaesth
, vol.105
, pp. 122-130
-
-
Flier, S.1
Post, J.2
Concepcion, A.N.3
Kappen, T.H.4
Kalkman, C.J.5
Buhre, W.F.6
-
13
-
-
58849162767
-
Toll-like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking
-
Versteeg D, Dol E, Hoefer IE, Flier S, Buhre WF, de Kleijn D et al. Toll-like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking. Shock 2009;31:21-7.
-
(2009)
Shock
, vol.31
, pp. 21-27
-
-
Versteeg, D.1
Dol, E.2
Hoefer, I.E.3
Flier, S.4
Buhre, W.F.5
de Kleijn, D.6
-
14
-
-
79958148771
-
Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with global registry of acute coronary events risk scoring and NT-proBNP
-
Dhillon OS, Narayan HK, Quinn PA, Squire IB, Davies JE, Ng LL. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with global registry of acute coronary events risk scoring and NT-proBNP. Am Heart J 2011;161:1163-70.
-
(2011)
Am Heart J
, vol.161
, pp. 1163-1170
-
-
Dhillon, O.S.1
Narayan, H.K.2
Quinn, P.A.3
Squire, I.B.4
Davies, J.E.5
Ng, L.L.6
-
15
-
-
84555204703
-
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure
-
Bayes-Genis A, de Antonio M, Galán A, Sanz H, Urrutia A, Cabanes R et al. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail 2012;14:32-8.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 32-38
-
-
Bayes-Genis, A.1
de Antonio, M.2
Galán, A.3
Sanz, H.4
Urrutia, A.5
Cabanes, R.6
-
16
-
-
77958564347
-
Interleukin family member ST2 and mortality in acute dyspnoea
-
Socrates T, DeFilippi C, Reichlin T, Twerenbold R, Breidhardt T, Noveanu M et al. Interleukin family member ST2 and mortality in acute dyspnoea. J Intern Med 2010;268:493-500.
-
(2010)
J Intern Med
, vol.268
, pp. 493-500
-
-
Socrates, T.1
DeFilippi, C.2
Reichlin, T.3
Twerenbold, R.4
Breidhardt, T.5
Noveanu, M.6
-
17
-
-
79960026972
-
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure
-
Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-25.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 718-725
-
-
Pascual-Figal, D.A.1
Manzano-Fernández, S.2
Boronat, M.3
Casas, T.4
Garrido, I.P.5
Bonaque, J.C.6
-
18
-
-
84859219085
-
ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain
-
Aldous SJ, Richards AM, Troughton R, Than M. ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain.J Cardiac Fail 2012;18:304-10.
-
(2012)
J Cardiac Fail
, vol.18
, pp. 304-310
-
-
Aldous, S.J.1
Richards, A.M.2
Troughton, R.3
Than, M.4
-
19
-
-
84866674781
-
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study
-
Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012;126:1596-604.
-
(2012)
Circulation
, vol.126
, pp. 1596-1604
-
-
Wang, T.J.1
Wollert, K.C.2
Larson, M.G.3
Coglianese, E.4
McCabe, E.L.5
Cheng, S.6
-
20
-
-
0037016036
-
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
-
Weinberg EO, Schimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002;106:2961-6.
-
(2002)
Circulation
, vol.106
, pp. 2961-2966
-
-
Weinberg, E.O.1
Schimpo, M.2
De Keulenaer, G.W.3
MacGillivray, C.4
Tominaga, S.5
Solomon, S.D.6
-
21
-
-
77951569359
-
ST2 and mortality in non-ST-segment elevation acute coronary syndrome
-
Eggers KM, Armstrong PW, Califf RM, Simoons ML, Venge P, Wallentin L et al. ST2 and mortality in non-ST-segment elevation acute coronary syndrome. Am Heart J 2010;159:788-94.
-
(2010)
Am Heart J
, vol.159
, pp. 788-794
-
-
Eggers, K.M.1
Armstrong, P.W.2
Califf, R.M.3
Simoons, M.L.4
Venge, P.5
Wallentin, L.6
-
22
-
-
3242728316
-
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
-
Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 2004;30:1468-73.
-
(2004)
Intensive Care Med
, vol.30
, pp. 1468-1473
-
-
Brunner, M.1
Krenn, C.2
Roth, G.3
Moser, B.4
Dworschak, M.5
Jensen-Jarolim, E.6
-
23
-
-
28844480491
-
Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions
-
Szerafin T, Brunner M, Horvath A, Szentgyorgyi L, Moser B, Boltz-Nitulescu G et al. Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions. Clin Lab 2005;51:657-63.
-
(2005)
Clin Lab
, vol.51
, pp. 657-663
-
-
Szerafin, T.1
Brunner, M.2
Horvath, A.3
Szentgyorgyi, L.4
Moser, B.5
Boltz-Nitulescu, G.6
-
24
-
-
62449245589
-
Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery
-
Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G et al. Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery. Thorac Cardiovasc Surg 2009;57:25-9.
-
(2009)
Thorac Cardiovasc Surg
, vol.57
, pp. 25-29
-
-
Szerafin, T.1
Niederpold, T.2
Mangold, A.3
Hoetzenecker, K.4
Hacker, S.5
Roth, G.6
-
25
-
-
55149116551
-
Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure
-
Boisot S, Beede J, Isakson S, Chiu A, Clopton P, Januzzi J et al. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail 2008;14:732-8.
-
(2008)
J Card Fail
, vol.14
, pp. 732-738
-
-
Boisot, S.1
Beede, J.2
Isakson, S.3
Chiu, A.4
Clopton, P.5
Januzzi, J.6
-
26
-
-
78649291119
-
Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure
-
Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdés Chávarri M et al. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol 2010;63:1171-8.
-
(2010)
Rev Esp Cardiol
, vol.63
, pp. 1171-1178
-
-
Bayes-Genis, A.1
Pascual-Figal, D.2
Januzzi, J.L.3
Maisel, A.4
Casas, T.5
Valdés Chávarri, M.6
-
27
-
-
84864109759
-
Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure
-
Manzano-Fernández S, Januzzi JL, Pastor-Pérez FJ, Bonaque-González JC, Boronat-Garcia M, Pascual-Figal DA et al. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure. Cardiology 2012;122:158-66.
-
(2012)
Cardiology
, vol.122
, pp. 158-166
-
-
Manzano-Fernández, S.1
Januzzi, J.L.2
Pastor-Pérez, F.J.3
Bonaque-González, J.C.4
Boronat-Garcia, M.5
Pascual-Figal, D.A.6
-
28
-
-
84856074303
-
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial
-
Kohli P, Bonaca MP, Kakkar R, Kudinova AY, Scirica BM, Sabatine MS et al. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clin Chem 2012;58:257-66.
-
(2012)
Clin Chem
, vol.58
, pp. 257-266
-
-
Kohli, P.1
Bonaca, M.P.2
Kakkar, R.3
Kudinova, A.Y.4
Scirica, B.M.5
Sabatine, M.S.6
-
29
-
-
79955943158
-
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure
-
Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 2011;4:180-7.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 180-187
-
-
Ky, B.1
French, B.2
McCloskey, K.3
Rame, J.E.4
McIntosh, E.5
Shahi, P.6
-
30
-
-
0035880170
-
Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation
-
Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164:277-81.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 277-281
-
-
Oshikawa, K.1
Kuroiwa, K.2
Tago, K.3
Iwahana, H.4
Yanagisawa, K.5
Ohno, S.6
-
31
-
-
80052818476
-
Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis
-
Hong YS, Moon SJ, Joo YB, Jeon CH, Cho ML, Ju JH et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011;26:1132-9.
-
(2011)
J Korean Med Sci
, vol.26
, pp. 1132-1139
-
-
Hong, Y.S.1
Moon, S.J.2
Joo, Y.B.3
Jeon, C.H.4
Cho, M.L.5
Ju, J.H.6
-
32
-
-
77950534152
-
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus
-
Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EYT et al. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 2010;49:520-7.
-
(2010)
Rheumatology
, vol.49
, pp. 520-527
-
-
Mok, M.Y.1
Huang, F.P.2
Ip, W.K.3
Lo, Y.4
Wong, F.Y.5
Chan, E.Y.T.6
-
33
-
-
68349099049
-
Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis
-
Wagenaar JFP, Gasem MH, Goris MGA, Leeflang M, Hartskeerl RA, van der Poll T et al. Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis 2009;3:e453.
-
(2009)
PLoS Negl Trop Dis
, vol.3
-
-
Wagenaar, J.F.P.1
Gasem, M.H.2
Goris, M.G.A.3
Leeflang, M.4
Hartskeerl, R.A.5
van der Poll, T.6
-
34
-
-
38449086201
-
Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model
-
van't Veer C, van den Pangaart PS, van Zoelen MAD, de Kruif M, Birjmohun RS, Stroes ES et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol 2007;179:7110-20.
-
(2007)
J Immunol
, vol.179
, pp. 7110-7120
-
-
van't Veer, C.1
van den Pangaart, P.S.2
van Zoelen, M.A.D.3
de Kruif, M.4
Birjmohun, R.S.5
Stroes, E.S.6
-
35
-
-
0024404517
-
A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor
-
Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 1989;258:301-4.
-
(1989)
FEBS Lett
, vol.258
, pp. 301-304
-
-
Tominaga, S.1
-
36
-
-
0035336425
-
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression
-
Sweet M, Leung B, Kang D, Sogaard M, Schulz K, Trajkovic V et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001;166:6633-9.
-
(2001)
J Immunol
, vol.166
, pp. 6633-6639
-
-
Sweet, M.1
Leung, B.2
Kang, D.3
Sogaard, M.4
Schulz, K.5
Trajkovic, V.6
-
37
-
-
31444440401
-
ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells
-
Takezako N, Hayakawa M, Hayakawa H, Aoki S, Yanagisawa K, Endo H et al. ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 2006;341:425-32.
-
(2006)
Biochem Biophys Res Commun
, vol.341
, pp. 425-432
-
-
Takezako, N.1
Hayakawa, M.2
Hayakawa, H.3
Aoki, S.4
Yanagisawa, K.5
Endo, H.6
-
38
-
-
79953777764
-
Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice
-
Yin H, Li XY, Yuan BH, Zhang BB, Hu SL, Gu HB et al. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clin Exp Immunol 2011;164:248-55.
-
(2011)
Clin Exp Immunol
, vol.164
, pp. 248-255
-
-
Yin, H.1
Li, X.Y.2
Yuan, B.H.3
Zhang, B.B.4
Hu, S.L.5
Gu, H.B.6
|